STOREBRAND ASSET MANAGEMENT AS
Position in RVMD — Revolution Medicines, Inc.
CIK 1685676
LYSAKER, Q8
Position in RVMD
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$5,189,746
New position
Shares Held
53,365
first reported quarter
Ownership
0.025%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026STOREBRAND ASSET MANAGEMENT AS holds $182,532,224 across 11 Biotechnology names. RVMD ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,567 | $45,800,268 | |
| 2 | RPRX |
Royalty Pharma plc
|
776,642 | $37,255,516 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
35,939 | $27,767,908 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
64,595 | $21,372,547 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
109,134 | $20,631,782 | |
| 6 | INSM |
INSMED Inc
|
90,826 | $14,851,867 | |
| 7 | INCY |
Incyte Corp
|
80,755 | $7,600,660 | |
| 8 | RVMD |
Revolution Medicines, Inc.
This page
|
53,365 | $5,189,746 |
All Filings in RVMD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,189,746 | 53,365 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||